Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients
Julia Dietz(National Institute for Health and Care Excellence), R. Zachoval, Elena Durmashkina(St. Josefs Hospital), R. Thimme, E. Giostra, Janett Fischer(Leipzig University), Kai‐Henrik Peiffer(Goethe University Frankfurt), J. Balavoine(Universität Hamburg), Tony Bruns(University of Birmingham), Thomas Discher, M. Löbermann, Christoph Neumann‐Haefelin(University of Freiburg), J. Hampe(Universität Hamburg), Beat Müllhaupt(University Hospital of Zurich), Christoph Antoni(Heidelberg University), Stefan Zeuzem(Goethe University Frankfurt), A. Rauch, Andreas Geier(Swiss Integrative Center for Human Health), Andreas Herrmann(DWI – Leibniz Institute for Interactive Materials), A. Teufel, U. Protzer, Andrea De Gottardi(Ente Ospedaliero Cantonale), Tobias Boettler(University of Freiburg), D. Hoffmann, M. Berning, Christoph Sarrazin(St. Josefs Hospital), Christophe Moreno(Genfit (France)), Johannes Vermehren, Tobias Götze, A. Kodal, Andreas Stallmach(Jena University Hospital), G. Dultz(Goethe University Frankfurt), Christiana Graf(Goethe University Frankfurt), Peter Buggisch(Institute for Interdisciplinary Medicine), Katja Deterding(Medizinische Hochschule Hannover), Andreas E. Kremer(Friedrich-Alexander-Universität Erlangen-Nürnberg), Thomas Berg(Leipzig University of Applied Sciences), Christoph P. Berg(University of Tübingen), Verena Keitel(Klinikum Magdeburg), Janina Trauth, N. Semmo, Kerstin Port(Medizinische Hochschule Hannover), R. Vogelmann, M. Gress, Thierry Gustot(Université Libre de Bruxelles), Jörn M. Schattenberg(Saarland University), Christian M. Lange(Goethe University Frankfurt), M. Ebert, Volker Ellenrieder(Universitätsmedizin Göttingen), Florian P. Reiter(Universitätsklinikum Würzburg)
Cited by 8
Related Papers
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k